title: Human phenylalanine hydroxylase mutations and hyperphenylalaninemia phenotypes: a metanalysis of genotype-phenotype correlations.
abstract: We analyzed correlations between mutant genotypes at the human phenylalanine hydroxylase locus (gene symbol PAH) and the corresponding hyperphenylalaninemia (HPA) phenotypes (notably, phenylketonuria [OMIM 261600]). We used reports, both published and in the PAH Mutation Analysis Consortium Database, on 365 patients harboring 73 different PAH mutations in 161 different genotypes. HPA phenotypes were classified as phenylketonuria (PKU), variant PKU, and non-PKU HPA. By analysis both of homoallelic mutant genotypes and of "functionally hemizygous" heteroallelic genotypes, we characterized the phenotypic effect of 48 of the 73 different, largely missense mutations. Among those with consistent in vivo expression, 24 caused PKU, 3 caused variant PKU, and 10 caused non-PKU HPA. However, 11 mutations were inconsistent in their effect: 9 appeared in two different phenotype classes, and 2 (I65T and Y414C) appeared in all three classes. Seven mutations were inconsistent in phenotypic effect when in vitro (unit-protein) expression was compared with the corresponding in vivo phenotype (an emergent property). We conclude that the majority of PAH mutations confer a consistent phenotype and that this is concordant with their effects, when known, predicted from in vitro expression analysis. However, significant inconsistencies, both between in vitro and in vivo phenotypes and between different individuals with similar PAH genotypes, reveal that the HPA-phenotype is more complex than that predicted by Mendelian inheritance of alleles at the PAH locus.
authors.affiliation: DeBelle Laboratory, McGill University-Montreal Children's Hospital Research Institute, Quebec, Canada.
authors.forename: E
authors.initials: E
authors.lastname: Kayaalp
authors.forename: E
authors.initials: E
authors.lastname: Treacy
authors.forename: P J
authors.initials: PJ
authors.lastname: Waters
authors.forename: S
authors.initials: S
authors.lastname: Byck
authors.forename: P
authors.initials: P
authors.lastname: Nowacki
authors.forename: C R
authors.initials: CR
authors.lastname: Scriver
mesh_terms: D000483:Alleles; D000818:Animals; D019556:COS Cells; D002881:Chromosomes, Human, Pair 12 / Q000235:genetics*; D004790:Enzyme Induction; D016368:Frameshift Mutation; D018740:Genetic Heterogeneity; D005838:Genotype; D006801:Humans; D010641:Phenotype; D010649:Phenylalanine / Q000097:blood*; D010651:Phenylalanine Hydroxylase / Q000096:biosynthesis / Q000235:genetics*; D010661:Phenylketonurias / Q000235:genetics*; D017354:Point Mutation; D012326:RNA Splicing; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis; D017384:Sequence Deletion
chemical_list: D011993:Recombinant Fusion Proteins; D010649:Phenylalanine; D010651:Phenylalanine Hydroxylase